文献速递血液净化与透析

血液透析漏治的国际差异、预测因素与结局:DOPPS研究

Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
PubMed 文献 · Am J Kidney Dis · 2018-08-23

基于DOPPS第五阶段(2012-2015)20国8501例维持性血透患者的前瞻性观察研究,分析非住院原因漏治情况。在4个月漏治风险>5%的国家中,漏治与全因死亡(HR 1.68)、住院及更差实验室指标和患者报告结局相关,且各国漏治风险差异超过50倍。

要点

  • 漏治与全因死亡风险升高独立相关(HR 1.68)。
  • 年轻、透析龄短、Kt/V低、抑郁症状多者漏治风险更高。
  • 漏治风险国家间差异巨大,提示潜在可干预。

核心结论

  • 在4个月漏治风险>5%的国家中,4个月内发生1次及以上漏治的HD患者死亡、住院及不良实验室指标和患者报告结局的风险更高。
  • 20国间4个月漏治风险差异超过50倍,提示漏治可能可干预。

研究设计与样本

  • 前瞻性观察研究,纳入DOPPS第五阶段(2012-2015)20国8501例透析超过120天的HD患者。
  • 纵向和横断面分析基于4个月漏治风险>5%国家的4493例患者。

主要发现

  • 4个月漏治风险从意大利和日本的<1%到美国的24%,各国差异超过50倍。
  • 漏治与全因死亡(HR 1.68;95%CI 1.37-2.05)、心血管死亡、猝死/心脏骤停、住院、血磷>5.5mg/dL、PTH>300pg/mL、血红蛋白<10g/dL、更高肾脏病负担及更差一般和心理健康相关。
  • 年轻、透析龄较短、HD治疗时间较短、Kt/V较低、到透析中心旅行时间较长和更多抑郁症状与漏治可能性更高相关。

临床怎么用

  • 对漏治风险高的患者(如年轻、透析龄短、Kt/V低、抑郁症状多、旅行时间长)应加强识别和干预。
  • 降低漏治可能改善HD患者的生存、住院及实验室指标和患者报告结局。

局限性

  • 可能存在残余混杂。
  • 横断面分析存在时间模糊性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Missed hemodialysis (HD) treatments not due to hospitalization have been associated with poor clinical outcomes and related in part to treatment nonadherence. Using data from the Dialysis Outcomes and Practice Patterns Study (DOPPS) phase 5 (2012-2015), we report findings from an international investigation of missed treatments among patients prescribed thrice-weekly HD. STUDY DESIGN: Prospective observational study. SETTING & PARTICIPANTS: 8,501 patients participating in DOPPS, on HD therapy for more than 120 days, from 20 countries. Longitudinal and cross-sectional analyses were performed based on the 4,493 patients from countries in which 4-month missed treatment risk was > 5%. PREDICTORS: The main predictor of patient outcomes was 1 or more missed treatments in the 4 months before DOPPS phase 5 enrollment; predictors of missed treatments included country, patient characteristics, and clinical factors. OUTCOMES: Mortality, hospitalization, laboratory measures, patient-reported outcomes, and 4-month missed treatment risk. ANALYTICAL APPROACH: Outcomes were assessed using Cox proportional hazards, logistic, and linear regression, adjusting for case-mix and country. RESULTS: The 4-month missed treatment risk varied more than 50-fold across all 20 DOPPS countries, ranging from < 1% in Italy and Japan to 24% in the United States. Missed treatments were more likely with younger age, less time on dialysis therapy, shorter HD treatment time, lower Kt/V, longer travel time to HD centers, and more symptoms of depression. Missed treatments were positively associated with all-cause mortality (HR, 1.68; 95% CI, 1.37-2.05), cardiovascular mortality, sudden death/cardiac arrest, hospitalization, serum phosphorus level > 5.5mg/dL, parathyroid hormone level > 300pg/mL, hemoglobin level < 10g/dL, higher kidney disease burden, and worse general and mental health. LIMITATIONS: Possible residual confounding; temporal ambiguity in the cross-sectional analyses. CONCLUSIONS: In the countries with a 4-month missed treatment risk > 5%, HD patients were more likely to die, be hospitalized, and have poorer patient-reported outcomes and laboratory measures when 1 or more missed treatments occurred in a 4-month period. The large variation in missed treatments across 20 nations suggests that their occurrence is potentially modifiable, especially in the United States and other countries in which missed treatment risk is high.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Al Salmi I, Larkina M, Wang M, et al. Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2018. PMID: 30146421. doi:10.1053/j.ajkd.2018.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。